Mastocytosis Manifested by Hepatosplenomegaly
- 10 September 1964
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 271 (11) , 533-535
- https://doi.org/10.1056/nejm196409102711102
Abstract
CURRENT interest in the function and pathophysiology of the mast cell has been exemplified by a recent symposium on the subject.1 However, arguments over the derivation of the mast cell and its function and role in diseases remain unresolved.Pathologic states involving the mast cell can take several forms, which have been arbitrarily divided into benign and malignant varieties. Mastocytosis is a condition caused by systemic hyperplasia of mast cells, the skin being one of the organs primarily involved in the majority of cases. The cutaneous lesions may be of several types, and a definite diagnosis can only be made . . .Keywords
This publication has 10 references indexed in Scilit:
- Systemic Mast Cell DiseaseAnnals of Internal Medicine, 1963
- The Mastocytosis Syndrome: Clinical and Biological StudiesAnnals of Internal Medicine, 1963
- QUANTITATIVE STUDIES WITH MAST CELLSAnnals of the New York Academy of Sciences, 1963
- Systemic mast cell diseaseThe American Journal of Medicine, 1962
- Histaminuria in Urticaria PigmentosaArchives of Dermatology, 1961
- Malignant Systemic Mast Cell Disease (Mastocytoma) in ManActa Medica Scandinavica, 1960
- PHARMACOLOGY OF THE TISSUE MAST CELLBritish Journal of Dermatology, 1958
- Splenic MastocytosisBlood, 1958
- Mast Cells in Human AtherosclerosisScience, 1954
- Mast Cells and Susceptibility to Experimental AtherosclerosisScience, 1953